Monika Czokolyova

Debrecen, HB, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis.

Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis.

Journal: Frontiers in medicine

Published: May 22, 2023

Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis.

Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis.

Journal: Rheumatology (Oxford, England)

Published: March 10, 2023

Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis.

Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis.

Journal: Biomolecules

Published: September 10, 2022

Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach.

Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach.

Journal: Frontiers in medicine

Published: August 04, 2022

Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients.

Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients.

Journal: Frontiers in medicine

Published: September 29, 2021

Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology.

Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology.

Journal: Biomolecules

Published: July 26, 2021

Prospective, simultaneous assessment of joint and vascular inflammation by PET/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status.

Prospective, simultaneous assessment of joint and vascular inflammation by PET/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status.

Journal: RMD open

Published: July 09, 2021

Associations of vascular and bone status in arthritis patients.

Associations of vascular and bone status in arthritis patients.

Journal: Scientific reports

Published: June 13, 2021

Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis.

Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: November 27, 2020

Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy.

Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy.

Journal: The Journal of rheumatology

Published: November 27, 2020

Complex assessment of bone mineral density, fracture risk, vitamin D status, and bone metabolism in Hungarian systemic sclerosis patients.

Complex assessment of bone mineral density, fracture risk, vitamin D status, and bone metabolism in Hungarian systemic sclerosis patients.

Journal: Arthritis research & therapy

Published: May 16, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026